AF_AFQ9NQ25F1

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	SLAM family member 7	identical protein binding protein binding binding	lymphocyte mediated immunity biological process involved in interspecies interaction between organisms response to stimulus immune response response to other organism defense response defense response to symbiont response to external stimulus leukocyte mediated cytotoxicity response to biotic stimulus immune effector process immune system process defense response to other organism response to stress natural killer cell mediated cytotoxicity lymphocyte mediated immunity biological process involved in interspecies interaction between organisms response to stimulus immune response response to other organism defense response defense response to symbiont response to external stimulus leukocyte mediated cytotoxicity response to biotic stimulus immune effector process immune system process defense response to other organism response to stress natural killer cell mediated cytotoxicity innate immune response leukocyte mediated immunity cellular process response to external biotic stimulus natural killer cell mediated immunity cell killing multicellular organismal process T cell activation cell activation lymphocyte activation leukocyte activation adaptive immune response natural killer cell activation cell adhesion	cell periphery cellular anatomical structure cell surface membrane plasma membrane external side of plasma membrane side of membrane

Chains	Accession	Name	Type
A	IPR036179	Immunoglobulin-like domain superfamily	Homologous Superfamily
A	IPR015631	CD2/SLAM family receptor	Family
A	IPR013783	Immunoglobulin-like fold	Homologous Superfamily
A	IPR013106	Immunoglobulin V-set domain	Domain
A	IPR007110	Immunoglobulin-like domain	Domain

Chains	Drug Target	Associated Disease
A	Pharos: Q9NQ25	plasma cell myeloma ulcerative colitis breast cancer interstitial cystitis lung cancer medulloblastoma periodontitis Relapse multiple myeloma Sjogren syndrome chronic obstructive pulmonary disease invasive ductal breast carcinoma lung carcinoma non-small cell lung carcinoma sarcoidosis tuberculosis plasma cell myeloma ulcerative colitis breast cancer interstitial cystitis lung cancer medulloblastoma periodontitis Relapse multiple myeloma Sjogren syndrome chronic obstructive pulmonary disease invasive ductal breast carcinoma lung carcinoma non-small cell lung carcinoma sarcoidosis tuberculosis cutaneous lupus erythematosus lung adenocarcinoma MALT lymphoma osteosarcoma psoriasis sinusitis

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.